Transgene to Participate in Upcoming Investor Meetings

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, todayannounced that its management team will meet institutional ...
PharmiWeb

Transgene to Deliver an Oral Presentation on its Individualized Neoantigen Therapeutic Vaccine TG4050 at the World Vaccine Congress

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced a 30-minute oral presentation on TG4050, the ...
Pharmabiz

Transgene and NEC Bio ink agreement to prepare the next steps of the development of TG4050 in head and neck cancer

Transgene and NEC Bio ink agreement to prepare the next steps of the development of TG4050 in head and neck cancer: Strasbourg, France Monday, April 6, 2026, 17:00 Hrs [IST] Trans ...

Availability of Transgene’s 2025 Universal Registration Document (URD)

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces ...
The Manila Times

Transgene Continues Progress to Reshape Early-Stage Cancer Treatment through Individualized Neoantigen Therapeutic Vaccines (INTV) Backed by Financial Visibility Until Early 2028

TG4050, Transgene’s first INTV, demonstrated durable clinical outcomes in resected head and neck squamous cell carcinoma (HNSCC) and potential to prevent cancer relapse "Together with the updated ...

Why Transgene (ENXTPA:TNG) Analysts Are Rewriting The Story Around Its €1.10 Valuation

Transgene’s updated analyst narrative keeps the fair value price target anchored at €1.10, indicating that the headline valuation marker is unchanged in the latest refresh. Bullish and bearish ...
GEN

Transgene and ProBioGen Collaborate on Individualized Cancer Vaccine Development

Transgene and ProBioGen, a CDMO, inked a license agreement for ProBioGen’s AGE1.CR.pIX ® suspension cell line which will combine ProBioGen’s specific production technology with the manufacturing ...
Phys.org

New method makes transgene-free gene editing even more promising

Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, government agencies, and the general public for decades. GMOs are banned in some ...
Business Wire

Transgene’s Two Innovative Platforms Progressing Well - Financial Visibility Extended Until End 2023

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, ...

Transgene S.A.: Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer

Strasbourg, France & Schiphol, Netherlands, April 2, 2026, 5:45 p.m. CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of ...